AIMC Topic: Positron-Emission Tomography

Clear Filters Showing 1 to 10 of 512 articles

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease.

Alzheimer's research & therapy
BACKGROUND AND OBJECTIVES: Early and cost-effective identification of amyloid positivity is crucial for Alzheimer's disease (AD) diagnosis. While amyloid PET is the gold standard, plasma biomarkers such as phosphorylated tau 217 (pTau217) provide a p...

AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment.

Nature communications
Alzheimer's disease (AD) diagnosis hinges on detecting amyloid beta (Aβ) plaques and neurofibrillary tau (τ) tangles, typically assessed using PET imaging. While accurate, these modalities are expensive and not widely accessible, limiting their utili...

Advanced finite segmentation model with hybrid classifier learning for high-precision brain tumor delineation in PET imaging.

Scientific reports
Brain tumor segmentation plays a crucial role in clinical diagnostics and treatment planning, yet accurate and efficient segmentation remains a significant challenge due to complex tumor structures and variations in imaging modalities. Multi-feature ...

A novel neuroimaging based early detection framework for alzheimer disease using deep learning.

Scientific reports
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that significantly impacts cognitive function, posing a major global health challenge. Despite its rising prevalence, particularly in low and middle-income countries, early diagnosi...

Machine learning model for predicting Amyloid-β positivity and cognitive status using early-phase F-Florbetaben PET and clinical features.

Scientific reports
This study developed machine learning models to predict Aβ positivity in Alzheimer's disease by integrating early-phase F-Florbetaben PET and clinical data to improve diagnostic accuracy. Furthermore, the study explored machine learning models to pre...

A Robust Residual Three-dimensional Convolutional Neural Networks Model for Prediction of Amyloid-β Positivity by Using FDG-PET.

Clinical nuclear medicine
BACKGROUND: Widely used in oncology PET, 2-deoxy-2- 18 F-FDG PET is more accessible and affordable than amyloid PET, which is a crucial tool to determine amyloid positivity in diagnosis of Alzheimer disease (AD). This study aimed to leverage deep lea...

Direct parametric reconstruction in dynamic PET using deep image prior and a novel parameter magnification strategy.

Computers in biology and medicine
BACKGROUND/PURPOSE: Multiple parametric imaging in positron emission tomography (PET) is challenging due to the noisy dynamic data and the complex mapping to kinetic parameters. Although methods like direct parametric reconstruction have been propose...

Brain metabolic imaging-based model identifies cognitive stability in prodromal Alzheimer's disease.

Scientific reports
The recent approval of anti-amyloid pharmaceuticals for the treatment of Alzheimer's disease (AD) has created a pressing need for the ability to accurately identify optimal candidates for anti-amyloid therapy, specifically those with evidence for inc...

PET image nonuniformity texture features for metastasis risk prediction in osteosarcoma.

Nuclear medicine communications
OBJECTIVE: PET image analysis provides tumor heterogeneity data related to neoadjuvant chemotherapy response (NACR) and metastatic risk in osteosarcoma. Ki-67 expression is used to predict metastasis. The accuracy of prediction models with image quan...

A review of multimodal fusion-based deep learning for Alzheimer's disease.

Neuroscience
Alzheimer's Disease (AD) as one of the most prevalent neurodegenerative disorders worldwide, characterized by significant memory and cognitive decline in its later stages, severely impacting daily lives. Consequently, early diagnosis and accurate ass...